Publications
Gilteritinib post TKI (2022)
Publication
Clinical outcomes in patients with relapsed/refractory FLT3- mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Read moreAML ELN guidance (2022)
Publication
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Read moreADMIRAL trial (2019)
Publication
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Read more